| http://www.w3.org/ns/prov#value | - Agent: Seaside Therapeutics, Inc.20120129941 - Treprostinil treatment for interstitial lung disease and asthma: The present invention describes methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of interstitial lung disease or asthma, or a condition, such as pulmonary fibrosis, associated with interstitial lung disea
|
